Babiker Saad Almugadam1,2, Mihad Khaleil Ibrahim3, Yinhui Liu1, Shen-Min Chen1, Chun-Hao Wang1, Chen-Yi Shao1, Bao-Wei Ren1, Li Tang4. 1. Department of Microecology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China. 2. Department of Microbiology, Faculty of Medical Laboratory Sciences, University of El Imam El Mahdi, Kosti, White Nile State, Sudan. 3. Department of Medicine, Kosti Teaching Hospital, Kosti, White Nile State, Sudan. 4. Department of Microecology, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China. tangli_2015cn@sina.com.
Abstract
BACKGROUND: Globally, urogenital and intestinal parasitosis remain significant health challenges. They are associated with rising morbidity, death, and many harmful outcomes. A little is known concerning parasitosis and type 2 diabetes mellitus. Our study planned to investigate the urogenital and intestinal parasitic infections among type 2 diabetes patients compare to non-diabetic (Control) individuals and examine the intensity of helminthiasis in both groups. METHODS: At Kosti Teaching Hospital (Sudan), 300 Urine and 300 stool samples have collected from 150 type 2 diabetes and 150 control individuals, along with the socio-demographic data using a structured questionnaire. The parasitic infections were examined by direct sedimentation technique for urine specimens. Whereas, for fecal samples, simple-direct saline, formal-ether concentration, Kato-Katz, and modified Ziehl-Neelsen techniques were used. RESULTS: Out of 150 type 2 diabetes patients studied, 31 (20.6%) and 14 (9.3%) had intestinal parasitosis and urogenital schistosomiasis, respectively. Whereas, 16 (10.6%) and 8 (5.3%) of the control group were infected, respectively. Compared to the control group, the odds of testing positive for either urogenital schistosomiasis (AOR: 2.548, 95% CI: 0.836-7.761, P = 0.100) or intestinal parasitic diseases (AOR: 2.099, 95% CI: 0.973-4.531, P = 0.059) were greater in diabetic individuals. Likewise, the intensities of helminthiasis were much higher in the diabetic patients and positively correlated with the duration of illness. The rate of urogenital schistosomiasis was also significantly different among the disease duration subcategories. CONCLUSIONS: Our study has highlighted the relationship of type 2 diabetes with urogenital and intestinal parasitic infections and enhanced our knowledge about the frequency of particular urogenital and intestinal parasites as well as the intensity of helminths infection in type 2 diabetes compared to non-diabetic individuals, which are important for further studies.
BACKGROUND: Globally, urogenital and intestinal parasitosis remain significant health challenges. They are associated with rising morbidity, death, and many harmful outcomes. A little is known concerning parasitosis and type 2 diabetes mellitus. Our study planned to investigate the urogenital and intestinal parasitic infections among type 2 diabetespatients compare to non-diabetic (Control) individuals and examine the intensity of helminthiasis in both groups. METHODS: At Kosti Teaching Hospital (Sudan), 300 Urine and 300 stool samples have collected from 150 type 2 diabetes and 150 control individuals, along with the socio-demographic data using a structured questionnaire. The parasitic infections were examined by direct sedimentation technique for urine specimens. Whereas, for fecal samples, simple-direct saline, formal-ether concentration, Kato-Katz, and modified Ziehl-Neelsen techniques were used. RESULTS: Out of 150 type 2 diabetespatients studied, 31 (20.6%) and 14 (9.3%) had intestinal parasitosis and urogenital schistosomiasis, respectively. Whereas, 16 (10.6%) and 8 (5.3%) of the control group were infected, respectively. Compared to the control group, the odds of testing positive for either urogenital schistosomiasis (AOR: 2.548, 95% CI: 0.836-7.761, P = 0.100) or intestinal parasitic diseases (AOR: 2.099, 95% CI: 0.973-4.531, P = 0.059) were greater in diabetic individuals. Likewise, the intensities of helminthiasis were much higher in the diabeticpatients and positively correlated with the duration of illness. The rate of urogenital schistosomiasis was also significantly different among the disease duration subcategories. CONCLUSIONS: Our study has highlighted the relationship of type 2 diabetes with urogenital and intestinal parasitic infections and enhanced our knowledge about the frequency of particular urogenital and intestinal parasites as well as the intensity of helminths infection in type 2 diabetes compared to non-diabetic individuals, which are important for further studies.
Authors: Zhonghan Yang; Viktoriya Grinchuk; Allen Smith; Bolin Qin; Jennifer A Bohl; Rex Sun; Luigi Notari; Zhongyan Zhang; Hiromi Sesaki; Joseph F Urban; Terez Shea-Donohue; Aiping Zhao Journal: Infect Immun Date: 2013-03-18 Impact factor: 3.441
Authors: Jaspreet Toor; Ramzi Alsallaq; James E Truscott; Hugo C Turner; Marleen Werkman; David Gurarie; Charles H King; Roy M Anderson Journal: Clin Infect Dis Date: 2018-06-01 Impact factor: 9.079
Authors: Wongani Nyangulu; Christina Sadimba; Joyce Nyirenda; George Twaibu; John Kamwendo; Kelvin Chawawa; Angella Masano; Elizabeth Chilinda; Sekeleghe Kayuni; Adamson S Muula; Kenneth Maleta Journal: Trop Med Health Date: 2022-08-19